» Articles » PMID: 37662840

Case Report: PIK3CA Somatic Mutation Leading to Klippel Trenaunay Syndrome and Multiple Tumors

Abstract

We report a case of Klippel Trenaunay Syndrome that was monitored both clinically and molecularly over a period of 9 years. A somatic mosaic mutation of (p(E545G)) was identified using both cfDNA NGS liquid biopsy and tissue biopsy. At the age of 56, due to intervening clonal mutations in background, she developed a squamous cell carcinoma in the right affected leg which was treated surgically. Nine years later, lung bilateral adenocarcinoma arose on mutated tissues supported by different clonal mutations. One year later, the patient died from metastases led by a new clone unresponsive to standard-of-care, immunotherapy-based. Our results highlight the presence of a molecular hallmark underlying neoplastic transformation that occurs upon an angiodysplastic process and support the view that mutated tissues must be treated as precancerous lesions. Importantly, they remark the effectiveness of combining cfDNA NGS liquid and tissue biopsies to monitor disease evolution as well as to identify aggressive clones targetable by tailored therapy, which is more efficient than conventional protocols.

Citing Articles

Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital.

El Sissy F, Bisdorff A, Perrier A, Guillerm E, Denis J, Favre L Mol Diagn Ther. 2025; .

PMID: 39899252 DOI: 10.1007/s40291-025-00770-0.


KRIT1 in vascular biology and beyond.

Glading A Biosci Rep. 2024; 44(7).

PMID: 38980708 PMC: 11263069. DOI: 10.1042/BSR20231675.

References
1.
Wang Q, Timur A, Szafranski P, Sadgephour A, Jurecic V, Cowell J . Identification and molecular characterization of de novo translocation t(8;14)(q22.3;q13) associated with a vascular and tissue overgrowth syndrome. Cytogenet Cell Genet. 2002; 95(3-4):183-8. PMC: 1579861. DOI: 10.1159/000059343. View

2.
Siegel D, Cottrell C, Streicher J, Schilter K, Basel D, Baselga E . Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics. J Invest Dermatol. 2017; 138(4):957-967. DOI: 10.1016/j.jid.2017.10.033. View

3.
Samuels Y, Waldman T . Oncogenic mutations of PIK3CA in human cancers. Curr Top Microbiol Immunol. 2010; 347:21-41. PMC: 3164550. DOI: 10.1007/82_2010_68. View

4.
Wang L, Hu H, Pan Y, Wang R, Li Y, Shen L . PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup. PLoS One. 2014; 9(2):e88291. PMC: 3922761. DOI: 10.1371/journal.pone.0088291. View

5.
Finegold D, Schacht V, Kimak M, Lawrence E, Foeldi E, Karlsson J . HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol. 2008; 6(2):65-8. PMC: 4298750. DOI: 10.1089/lrb.2008.1524. View